Fundmental and clinical investigations with a new antibiotic, fosfomycin were performed with the results which may lead to the following conculsion.
1)
In vitro antibacterial activity: The minimal inhibitory concentration (MIC) of fosfomycin was measured by an agar plate dilution method using heart infusion agar (Eiken). Fosfomycin revealed an excellent, broad spectrum antibacterial activity against 24 standard strains of various bacteria. The MIC of fosfomycin against 80 strains of coagulase positive Staphylococcus aureus isolated from otorrhoea was distri- buted over range of 0.78 to 100 mcg/ml, with a peak being observed particulary at 6.25 mcg/ml. The MIC against 60 strains of Pseudomonas aeruginosa was 1.56 to 100 mcg/ml of fosfomycin, showing its peak at 12.5 mcg/ml. Other strains of Escherichia coli, Proteus mirabilis and Klebsiella pneumoniae were also examined on their sensi- tivity to fosfomycin as well as other antibiotics.
2) Blood concentration: The blood concentration of fosfomycin in healthy adults who were given 1g a single oral administration reached maximum of 5.77 mcg/ml two hours after administration. Even at 6 hours after administration, clinically effective serum fosfomycin concentration 0.8 mcg/ml was still demonstrable.
3) Concentration in tissues: Fosfomycin activity was demonstrable at the concentration of 0.6 to 0.88 mcg/g in human palatine tonsilla, and mucous membrane of maxillary specimen two hours after the administration of 1 g. Further, the serum concentration of fosfomycin was then 4.8 to 6.2 mcg/ml.
4) Results of clinical treatment: When fosfomycin was oral administration in 32 cases of representatlive infection in the otorhinolaryngologic field, it was excellent in 14 cases, good in 13 cases, fair in 4 cases and poor in one case. When the cases in which it was excellent and good in 27 cases, that is a ratio of effectiveness of 84.4 percent.
5) Side effect: No side effect was shown with the oral administration of fosfomycin. The comparative examination of hepatic function, electrocyte and auditory acuity before and after the administration showed no significant disturbance.
View full abstract